Pharmaceutical formulations with controlled release of the...

Details Pharmaceutical formulations with controlled release of the... Pharmaceutical formulations with controlled release of the...

A - Human Necessities

61

K

167/169, 167/231

A61K 47/38 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01)

Patent

CA 1298784

Case 100-6717 Abstract of the Disclosure A controlled release formulation for oral administration comprising - an active substance chosen from the group of Pindolol and a 4-(2,1, 3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester, - a pharmaceutically acceptable hydrophilic swellable substance and containing optionally a pharmaceutically acceptable inert fatty material in addition. The formulation has an excellent bioavailability and practically no food interaction after administration. 3700/KD/AB

519302

Affiliated with

Also associated with

Rating

Pharmaceutical formulations with controlled release of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations with controlled release of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations with controlled release of the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1173183